ABSTRACT Background: Effects of prenatal iron supplementation on maternal postpartum iron status and early infant iron homeostasis remain largely unknown. Objective: We examined iron absorption and growth in exclusively breastfed infants in relation to fetal iron exposure and iron status during early infancy. Design: Longitudinal, paired iron-absorption ( 58 Fe) studies were conducted in 59 exclusively breastfed Peruvian infants at 2-3 mo of age (2M) and 5-6 mo of age (5M). Infants were born to women who received $5100 or #1320 mg supplemental prenatal Fe. Iron status was assessed in mothers and infants at 2M and 5M. Results: Infant iron absorption from breast milk averaged 7.1% and 13.9% at 2M and 5M. Maternal iron status (at 2M) predicted infant iron deficiency (ID) at 5M. Although no infants were iron deficient at 2M, 28.6% of infants had depleted iron stores (ferritin concentration ,12 mg/L) by 5M. Infant serum ferritin decreased (P , 0.0001), serum transferrin receptor (sTfR) increased (P , 0.0001), and serum iron decreased from 2M to 5M (P , 0.01). Higher infant sTfR (P , 0.01) and breast-milk copper (P , 0.01) predicted increased iron absorption at 5M. Prenatal iron supplementation had no effects on infant iron status or breast-milk nutrient concentrations at 2M or 5M. However, fetal iron exposure predicted increased infant length at 2M (P , 0.01) and 5M (P , 0.05). Conclusions: Fetal iron exposure affected early infant growth but did not significantly improve iron status or absorption. Young, exclusively breastfed infants upregulated iron absorption when iron stores were depleted at both 2M and 5M.
INTRODUCTION
An estimated 1.6 billion people worldwide are anemic (1, 2) and iron deficiency (ID) 4 is the leading cause of anemia (1, 3) . Pregnant women are at increased risk of anemia and ID because of, in part, increased nutritional requirements of pregnancy coupled with a lack of adequate dietary iron intake and bioavailability to meet these increased demands (3, 4) . In resourcelimited settings, it has been estimated that 50% of pregnant women had anemia (1) compared with 12-25% in developed regions (3, 5, 6) . When anemia or ID occurs during pregnancy, risk of maternal (7) and infant mortality (8) is increased, but little is known about how this affects early infant iron homeostasis or growth.
The impact of maternal iron status and iron supplementation during pregnancy on neonatal iron status has not been fully characterized. Several studies have shown no significant association between maternal and infant iron status (9, 10) , whereas other evidence has suggested an association between maternal iron status in pregnancy and infant iron stores postpartum (11) (12) (13) (14) ; maternal iron-deficiency anemia (IDA) in pregnancy has been associated with compromised fetal iron reserves (11, (15) (16) (17) . Recent data by Roberfroid et al (18) have indicated that the physiologic anemia of pregnancy occurs even in women receiving iron supplementation.
Several studies have shown that placental iron transfer can be upregulated when maternal or fetal iron stores are limited (19) (20) (21) (22) (23) . We have previously reported that a significantly larger fraction of maternally ingested iron is transferred to the fetus in women with depleted iron stores (23, 24) . Recent animal studies also suggested that the timing at which iron supplementation is initiated during pregnancy may also influence subsequent neonatal outcomes (25) . Although acute studies of placental iron transport have highlighted the adaptability of maternal-fetal iron partitioning, little is known about the long-term impact of this transfer on early iron homeostasis. In Peru, the estimated prevalence of anemia in infants 6-8 mo old is 69.3% (26) ; reasons for this high prevalence in relation to early iron absorption need to be investigated.
To address this issue, we conducted longitudinal, paired ironabsorption studies in exclusively breastfed Peruvian infants at 2 and 5 mo of age to 1) characterize longitudinal determinants of iron absorption from breast milk in young infants as the iron stores of birth are depleted and 2) examine the impact of fetal iron exposure on early infant iron homeostasis and growth.
SUBJECTS AND METHODS

Study population
Two groups of Peruvian women and their 2-3-mo-old infants were recruited from Villa El Salvador, which is a low-income periurban area of Lima, Peru. One group of women (n = 30) had received supplemental iron [60 mg Fe/d for $3 mo during pregnancy for a total of $5100 mg supplemental prenatal iron (+Fe)], whereas the other group (n = 29) had not consumed iron supplements or consumed ,1 mo of supplemental iron during pregnancy [defined as #1320 mg supplemental prenatal Fe (2Fe) across pregnancy]. Maternal supplemental iron intake and adherence during pregnancy was evaluated by self-report. This study was conducted during 1998; at that time, pregnant women receiving care at health centers frequently did not ingest iron supplements either by low adherence to prenatal supplementation or because supplements were not regularly available in health centers. Recent survey data on prenatal iron supplementation (60 mg/d) in this community reported an average intake of 6360 mg Fe (IQR: 4860-7980 mg Fe) over the course of pregnancy (27) .
All infants recruited were receiving care at the well baby clinic at the Cesar Lopez Silva Hospital. Infants were eligible for participation if they were 2-3 mo old, healthy, full-term singletons ($37 to ,42 wk of gestation) with a birth weight $2500 g. Data on infant weight and length at birth were obtained from medical records. Infants were exclusively breastfed (ie, none had received any infant formula, herbal infusions, or foods), had not received any supplemental iron, and lived in Lima (at sea level) since birth. The study protocol was explained in detail to mothers by the field nurse and study doctor, and informed written consent was obtained before study enrollment. The study protocol was approved by the Committee on Human Research at Johns Hopkins Bloomberg School of Public Health and by the Institutional Review Board at the Instituto de Investigación Nutricional, Lima, Peru.
Study design
Longitudinal, paired iron-absorption ( 58 Fe) studies were undertaken in infants at 2-3 mo of age (2M) and again at 5-6 mo of age (5M). All study visits were conducted at the outpatient well baby clinic in Cesar Lopez Silva Hospital, Villa El Salvador, Lima, Peru. On the morning of the first iron-absorption study, the infant was examined by the study pediatrician, weight was measured by using a digital scale (SECA) (610 g), and recumbent length was measured to the nearest 0.1 cm by using a wooden measuring board. Each infant then had a 3-mL venous blood sample collected to assess baseline iron status, including hemoglobin, serum transferrin receptor (sTfR), serum ferritin (SF), and C-reactive protein (evacuated tubes containing EDTA; SARSDET). Breastmilk samples were collected from each mother into containers free from trace minerals; samples were obtained from early, middle, and late feed for assessment of iron, zinc, and copper concentrations. A maternal 3-mL venous blood sample was obtained on the day the infant was dosed at both 2M and 5M to evaluate the same iron-status indicators as measured in each infant.
In the initial iron-absorption studies, women expressed breast milk into a sterile trace mineral-free container, iron tracer (150 mg 58 Fe) was added to the expressed breast milk, and the mixture was allowed to sit overnight in a cold room on a shaker. At the clinic the next morning, infants were fed the extrinsically labeled breast milk (the container with milk was warmed in hot water) from a bottle ad libidum after a 2-h fast, and the quantity of milk and tracer ingested was determined by preweighing and postweighing the feed. However, the initial iron-absorption data from the first 9 infants were much lower than anticipated on the basis of existing literature at the time the study was undertaken. As a result, to ensure that all tracer was delivered, the study design was modified to administer 150 mg 58 Fe (after a 2-h fast) in a flavored syrup by syringe directly into the infant's mouth. Then, mothers breastfed their infants ad libidum. Infant weight was recorded before and after the feeding interval to assess the total intake of breast milk. Statistical analyses were conducted both with and without adjustment for the method of tracer administration; there were no significant differences in iron absorption in subjects who received tracer that had equilibrated in breast milk overnight (n = 15; 9 +Fe and 6 2Fe), compared with those who received tracer alone before being breastfed (n = 44; 21 +Fe and 23 2Fe). Thus, the dosing method was not adjusted for in subsequent analyses.
Syringes were weighed before and after dosing to determine the exact quantity of isotope administered. All mother and infant pairs studied remained in the clinic for 1 h postdosing to ensure that tracer was not regurgitated; no breast milk, other food, or liquid was given for 2 h after the feed that contained the iron dose was completed. Anthropometric, dietary, and health data were collected. Fourteen days after dosing, mothers and infants returned to the study hospital. A 3-mL venous blood sample was collected to assess concentrations of stable iron isotopes and biochemical indicators in infants. Anthropometric, dietary, and health data were also collected. After the blood collection, mothers and infants returned home.
Three months after the first iron-absorption study, motherinfant pairs returned to the study hospital, and a second iron absorption study was conducted by using the same labeling method as used at the first study except that a 3-mL venous blood sample was collected from each infant before dosing to assess baseline 58 Fe enrichment, and the 58 Fe dose was increased to 200 mg. The baseline enrichment at 5M was used as the new baseline value for the second absorption-study calculations. Maternal blood samples were also collected for the same analyses as those measured in the first study. As in the first study, the mother and infant remained in the clinic for the following hour postdosing to ensure that tracer was not regurgitated and the same anthropometric, biochemical, dietary, and health data were collected. Fourteen days after the second dosing study, mothers and infants returned to the study hospital, and a venous blood sample (3 mL) was obtained from each infant to assess iron enrichment in red blood cells and concentrations of biochemical indicators. Anthropometric data, dietary, and health data were also collected, and mothers and infants returned home. At the end of the second study, any mother or infant who was shown to be anemic was treated for anemia in accordance with standard of care guidelines for the WHO and government of Peru (3).
Biochemical indicators
Hemoglobin concentrations were assessed in whole blood samples by using the Hemocue method. The packed cell volume was analyzed by using the microhematocrit method. SF was measured by using an ELISA with human antiferritin and antiferritin peroxidase antibodies purchased from DAKO. sTfR was measured by using a commercially available ELISA (Quantikine; R&D Systems). Laboratory samples were tested in batches by an experienced biochemist at Instituto de Investigación Nutricional, and instruments were calibrated daily by using standardized procedures.
Preparation of stable iron isotope
A stable iron isotope ( 58 Fe at 93.13% enrichment) was purchased in elemental form from Trace Sciences International. The metal was converted into ferrous sulfate solutions (0.5 mg/ mL) according to the procedure of Kastenmayer et al (28) , except that no ascorbic acid was added during the tracer preparation to avoid its influence on iron absorption. Isotope solutions were checked for sterility before administration. The 58 Fe enrichment of the final ferrous sulfate tracer solution was determined by using magnetic sector thermal ionization mass spectrometry (Thermoquest Triton TI), and the total iron content was measured by using atomic absorption spectrophotometry (Perkin Elmer 3300;Perkin Elmer).
Isolation of iron from red blood cells
Approximately 1 mL whole blood was digested on a hot plate with Ultrex nitric acid following previously published methods (24, 29) . When the digest was clear, it was evaporated to dryness, reconstituted, and iron was extracted from this digest by using anion-exchange chromatography as previously reported (24, 29) . After the iron was eluted from the column, the sample was dried and reconstituted in 30 mL 0.3N ultrapure nitric acid.
Measurement of iron isotope enrichment
Extracted iron (10 mL) was loaded onto rhenium filaments and isotopic ratios ( 58 Fe: 56 Fe ratios normalized for isotopic fractionation by using the 54 Fe: 56 Fe ratio) were analyzed by using a magnetic sector thermal ionization mass spectrometer (Thermoquest TI). The instrumentation achieved a relative SD of 0.16% for the 58 Fe isotope used.
Iron-absorption calculations
The amount of circulating iron in each infant was estimated after assuming that the blood volume was 80 mL/kg by using the following equation: The percentage of iron absorption was determined by measuring the incorporation of 58 Fe tracer into red blood cells collected 14 d postdosing by using previously reported equations (29) and assuming that 90% of the absorbed iron was incorporated into red blood cells (28) .
Statistical analyses
Linear regression was used to examine associations between iron-status indicators and iron absorption at 2M and 5M and assess determinants of iron absorption. Binomial regression was used to obtain risk ratio estimates (30) (31) (32) to examine the effect of fetal iron exposure on categorical outcomes. To adjust for multiple hypothesis testing, significance was determined after applying the Bonferroni correction. All P values presented are original (unadjusted) P values for interpretation purposes, and the threshold used to determine statistical significance was
where a is the level of significance (a = 0.05), and n is the number of multiple comparison tests conducted. If results were significant after the application of the Bonferroni correction, the significance is reported in the text. Conventional cutoffs were used to categorize risk factors, where available; otherwise, medians were used to classify variables. Anemia was defined as hemoglobin concentrations ,12.0 g/dL in postpartum women and ,11.0 g/dL in infants in accordance with WHO criteria and clinical guidelines in Peru (3). ID was defined as SF concentrations ,12 mg/L in both mothers and infants (5) . IDA was defined in the presence of both anemia and depleted ferritin stores. Maternal sTfR concentrations .5.33 mg/L were classified as ID on the basis of recent NHANES data from nonpregnant women (33) . BMI (in kg/m 2 ) was defined as the ratio of weight to height squared. Infant ponderal index was calculated as the ratio of grams to the length cubed (g/cm 3 3 100). Ferritin values were log-transformed to account for the nonnormal distribution of this variable, but values in the text are presented as nontransformed values for interpretation purposes. In predictor analyses, variables with univariate P values ,0.20 were included in each of the multivariate regression models and retained if their P values were ,0.05.
We examined potential confounders, and adjusted all gestational iron exposure and growth analyses for infant sex. The missing indicator method was used to account for missing predictor data (34) .
Potential predictors of study outcomes were also examined as continuous variables. We explored the potential nonlinearity of relations between covariates and outcomes nonparametrically by using stepwise restricted cubic splines (35, 36) . We used tests for nonlinearity by using the likelihood ratio test and comparing the model with only the linear term to the model with the linear and the cubic spline terms. If nonlinear associations are not reported, they were not significant. Statistical analyses were performed with SAS software (version 9.3; SAS Institute Inc).
RESULTS
Baseline characteristics of the 59 women and infant pairs included in the analyses are presented in Table 1 . The average age of women in the study was 24.3 y, and the average BMI was 25.2. None of the women were underweight (BMI ,18.5), and 50.9% of women were overweight (BMI $25.0) at the 2M study. Of the 59 infants initially enrolled, 30 infants were born to +Fe women, and 29 infants were born to 2Fe women (#1320 mg Fe supplementation across gestation).
Maternal and infant iron status at 2M and 5M are presented in Table 2 . At the 2M postpartum baseline assessment, 64.9% of IRON ABSORPTION IN BREASTFED PERUVIAN INFANTS women were anemic, with a mean (6SD) hemoglobin concentration of 11.4 6 1.6 g/dL. The prevalence of anemia in infants was similarly high; 77.2% of infants had hemoglobin concentrations ,11.0 g/dL (ranging from 8.0 to 14.6 g/dL, with 31.6% and 8.9% of infants with hemoglobin concentrations ,10.0 and ,9.0 g/dL, respectively). Despite the high prevalence of infant anemia, maternal and infant ferritin concentrations averaged 20.6 6 20.3 and 164.46 103.8 mg/L, respectively, at 2M. A total of 49.0% of mothers were iron deficient (ferritin concentration ,12 mg/L), and 36.7% of mothers had IDA at 2M compared with 31.9% (P = 0.01) and 21.3% (P . 0.05) of mothers at 5M postpartum. Although no infants had ID (ferritin ,12 mg/L) or IDA at 2M, 28.6% of infants had ferritin concentrations ,12 mg/L, 59.2% of infants had ferritin concentrations ,30 mg/L, and 24.5% of infants had IDA at 5 mo of age. Prenatal iron supplementation had no significant effects on indicators of postpartum maternal or infant iron status measured, except hematocrit and sTfR (compared with infants born to 2Fe mothers, infants born to +Fe mothers had higher hematocrit and sTfR at 2M; P , 0.05). After correction for multiple hypothesis testing, prenatal iron supplementation had no significant effects on indicators of postpartum maternal or infant iron status measured (P . 0.0025).
In analyses of correlations between maternal and infant iron status at both 2M and 5M time points, maternal hemoglobin concentrations were associated with infant hemoglobin at both time points; low maternal hemoglobin concentrations were significantly associated with low infant hemoglobin concentrations at both 2M (R = 0.38, P = 0.007) and 5M (R = 0.31, P = 0.02), although the magnitude of association decreased at 5M. Maternal and infant hematocrit were significantly correlated at 5M (R = 0.42, P = 0.01). Infants born to iron-deficient mothers (at 2M) were significantly more likely to be iron deficient at 5M (R = 0.33, P = 0.008), irrespective of iron group.
In analyses of longitudinal changes in maternal and infant iron status between 2M and 5M, maternal sTfR significantly decreased between 2M and 5M (P = 0.02); and maternal serum iron significantly increased during the follow-up period (P = 0.01). There were no significant changes in maternal hemoglobin, SF, or hematocrit between 2M and 5M. Although no infants had ferritin concentrations ,12 mg/L at 2M, infant SF significantly decreased (P , 0.0001), infant sTfR significantly increased (P , 0.0001), and infant serum iron significantly decreased between 2M and 5M (P , 0.01). Although significant changes in infant iron stores were apparent, there were no significant changes in infant hemoglobin, hematocrit, or CRP between 2M and 5M, nor were there any significant differences in changes in any of the iron status indicators previously mentioned by gestational iron exposure ( Table 2) . As expected, infant weight (P , 0.0001) and length (P , 0.0001) significantly increased, and the ponderal index (P , 0.001) significantly decreased between 2M and 5M (Table 1) . Findings from these analyses remained significant after correction for multiple hypothesis testing, except for changes in maternal sTfR (,0.05 but .0.0125).
Breast-milk micronutrient concentrations and infant iron absorption at 2M and 5M and average changes between time points are presented in Table 3 . Breast-milk iron concentrations decreased between 2M and 5M, although this change was not 1 For statistical analyses, linear regression and binomial regression were used to examine differences in characteristics between iron groups. **No significant differences between the 2 groups after correction for multiple hypothesis testing, except for infant length at 2M, P , 0.01. 2M, 2-3 mo of age; 5M, 5-6 mo of age; 2Fe, infants born to women who received #1320 mg supplemental prenatal Fe; +Fe, infants born to women who received $5100 mg supplemental prenatal Fe.
2 Mean 6 SD (all such values). 3 Overweight was defined as BMI (in kg/m 2 ) $25. statistically significant (P . 0.05). In contrast, breast-milk copper (P = 0.001) and zinc (P , 0.001) concentrations both significantly decreased across the study period after adjustment for multiple hypothesis testing. Iron absorption from breast milk averaged 7.1 6 6.6% and 13.9 6 12.1% at 2M and 5M, respectively (Table 3) . Iron absorption tended to increase between 2M and 5M (P = 0.09), which was consistent with the response to the depletion of iron stores. Although the percentage iron absorption tended to increase, because of the low iron content of breast milk, this increase would not lead to a marked increase in net iron absorption. There were no significant associations of fetal iron exposure and subsequent iron absorption at 2M and 5M or on changes between time points. There were no significant differences in iron absorption in subjects who received tracer that had equilibrated in breast milk overnight (n = 15) compared with in subjects who received the tracer alone before being breastfed (n = 44) [median (IQR): 4.0% (2.1-5.8%) equilibrated compared with 5.1% (3.4-9.5%) nonequilibrated at 2M; 7.7% (3.9-8.8%) equilibrated compared with 10.4% (6.5-19.4%) nonequilibrated at 5M]. In analyses of the method of dose administration (equilibrated compared with nonequilibrated with breast milk) and iron absorption, there were no significant differences between iron absorption at 2M and 5M or paired changes between time points after adjustment for multiple hypothesis testing.
The value of a 90% red blood cell incorporation rate (28) was used to be consistent with other data reported in healthy infants (37) (38) (39) and, in particular, to be consistent with values used in healthy infants from the same Peruvian community (37) . Other published literature has used lower red blood cell incorporation values that ranged from 23% to 80% (40, 41) . If the middle range of these estimates were used (60%), the average ironabsorption value obtained would have been 10.6 6 9.9% and 20.9 6 18.1% at 2M and 5M, respectively (90%: 7.1 6 6.6% at 2M and 13.9 6 12.1% at 5M; 80%: 8.0 6 7.4% at 2M and 15.7 6 13.6% at 5M). Fomon et al (41) reported that erythrocyte incorporation of an orally administered 58 Fe tracer was 52% in older infants (168 d old) compared with 23% in younger infants (56 d old) ; the use of Fomon et al (41) values of 23% and/or 52% would have increased our absolute absorption results further (23%: 27.8 6 25.8% at 2M; 52%: 24.1 6 20.9% at 5M; or 23%: 54.5 6 47.2% at 5M) but would not have changed the relative associations we reported for other observations.
Associations of breast-milk nutrient concentrations and infant iron absorption are presented in Table 4 . Breast-milk nutrient concentrations at 2M were not significantly associated with infant iron absorption at 2M (P . 0.05). Breast-milk iron concentrations at 5M (P = 0.07) and changes in iron concentrations between 2M and 5M (P = 0.04) were associated with increased infant iron absorption at 5M. Higher breast-milk copper concentrations (5M) (P = 0.03) were associated with significantly increased infant iron absorption at 5M. After adjustment for multiple hypothesis testing, these associations were no longer significant (P , 0.05 but .0.0167). There were no significant differences in associations between breast-milk 1 All values are means 6 SDs. For statistical analyses, linear regression was used to examine differences in iron absorption and breast-milk nutrient concentrations by iron supplementation. ***Remained significant after correction for multiple hypothesis testing (P , 0.01). 2M, 2-3 mo of age; 5M, 5-6 mo of age; 2Fe, infants born to women who received #1320 mg supplemental prenatal Fe; +Fe, infants born to women who received $5100 mg supplemental prenatal Fe. Results from analyses of predictors of infant iron absorption at 2M and 5M are presented in Table 5 . Maternal anemia (2M) (P = 0.02) and higher infant sTfR concentrations (2M) (P = 0.02) were associated with increased infant iron absorption at 2M. In analyses of predictors of iron absorption at 5M, breast-milk copper concentrations (5M) (P , 0.01) and infant sTfR concentrations (5M) (P , 0.01) were associated with increased infant iron absorption (5M).
Associations of fetal iron exposure and infant length, weight, and ponderal index are presented in Table 6 . Fetal iron exposure was not associated with differences in birth length but was associated with significantly greater infant length at 2M (P , 0.01) and 5M (P , 0.05), indicative of a change in the early tempo of growth between these 2 groups. There were no significant effects of fetal iron exposure on infant weight at any time point (birth, 2M, or 5M). Fetal iron exposure was associated with a significantly reduced ponderal index at 2M (P , 0.05). Results in analyses of fetal iron exposure on infant growth remained similar (and more significant) after adjustment for infant sex (Table 6) , and the effects of iron exposure on infant length at 2M and 5M remained significant (P , 0.01) after adjustment for multiple hypothesis testing.
DISCUSSION
In this study, anemia and ID were common in lactating women at 2 and 5 mo postpartum and in their exclusively breastfed infants. Although there are limited data on the iron status of postpartum women and young infants, the prevalence of anemia and ID in this study were similar to previous data from resourcelimited settings (1, 2) and higher than in studies in pregnant women (42) (43) (44) (45) and older infants (37, 46, 47) . In an analysis of data from 6 studies in exclusively breastfed infants at 6 mo of age, the prevalence of ID (SF ,12 mg/L) was 6% in Sweden, 17% in Mexico, 13-25% in Honduras, and 12-37% in Ghana (46) . In a previous study in 6-12-mo-old Peruvian infants, 67% of infants were anemic and 60% were iron deficient (SF concentration ,20 mg/L) (47) . National surveys in Peru have reported an anemia prevalence of 69% (6-8 mo of age) to 72% (9-11 mo of age) in older infants (26, 37) . However, little data are available from infants ,6 mo of age, and most data relied on cross-sectional assessments.
The lack of normative iron status data in young, healthy infants may have been attributable to challenges in obtaining venous samples and the belief that, in most instances, the iron endowment of birth should be sufficient to maintain early iron status over the first 6 mo of life. In this study, iron stores of birth were significantly depleted between 2 and 5 mo of age; nearly onethird of infants had depleted iron stores (SF concentration ,12 mg/L), and 78.9% of infants were anemic by 5M. These results suggested that these full-term, exclusively breastfed Peruvian infants were not endowed with sufficient body iron at birth to meet requirements for growth and development over the first 4-6 mo of life (48, 49) . It is known that delayed cord clamping has a considerable impact on infant iron status (50, 51) and can increase neonatal blood volume by 60% (52) and red blood cells by .30% (53). Although we did not have data on cord-clamping times in these infants, delayed cord clamping is routinely undertaken in the Villa El Salvador community. Young, exclusively breastfed infants may be vulnerable to ID and IDA unless intestinal iron absorption can be upregulated in response to iron demands.
Infant iron absorption from breast milk in this study (2M: 7.1 6 6.6%; 5M: 13.9 6 12.1%) was similar to data from a previous Swedish study in which iron absorption from tracer given with a breast-milk feed averaged 16.4 6 11.4% in 5-6-mo-old infants and 25.7 6 17.2% in 5-9-mo-old infants (54) . However, these data were lower than the 36.8 6 9.3% (anemic) and 41.8 6 7.9% (nonanemic) iron absorption reported in 5-6-mo-old nonexclusively breastfed Peruvian infants when tracer was administered along with breast milk (37) . 1 All values are parameters 6 SEs. Infant length, weight, and ponderal index are presented for the iron-unsupplemented group; the difference (6SE) is the average difference of infant length, weight, and ponderal index between iron-supplemented and -unsupplemented groups. For statistical analyses, binomial regression was used to obtain risk-ratio estimates to examine the effect of fetal iron exposure on categorical outcomes. **Remained significant after correcting for multiple hypothesis testing, P , 0.0167. 2M, 2-3 mo of age; 5M, 5-6 mo of age; 2Fe, infants born to women who received #1320 mg supplemental prenatal Fe; +Fe, infants born to women who received $5100 mg supplemental prenatal Fe.
2 After adjustment for infant sex.
In adults, absorption of nonheme iron is regulated in response to iron stores (55), but the degree to which this occurs over early infancy is uncertain. Data from Honduras and Sweden suggested there is a developmental delay in the regulation of iron absorption, and healthy neonates do not develop the ability to regulate iron absorption in response to iron stores until 6-9 mo of age (54, 56) . However, a previous study from Peru showed that infants with low iron stores (SF concentration ,12 mg/L) upregulated iron absorption from breast milk at 5-6 and 9-10 mo of age (37) . The current study provides evidence that this effect may occur even earlier, as early as 2-5 mo of age.
The effects of maternal iron supplementation on iron status have been equivocal to date. In the current study, supplemental gestational iron intake had no significant effects on maternal or infant iron status, breast-milk iron concentrations, or infant iron absorption in early infancy, although iron intake and dietary variability were low in this population (57) . Despite a lack of an impact on iron status, in utero iron exposure significantly influenced early growth potential, as evidenced by increased infant length at 2M and 5M. Findings from studies of the effects of prenatal iron supplementation on early infant growth have been inconsistent. In a randomized placebo-controlled trial of iron supplementation in Niger in pregnant women, prenatal iron supplementation was associated with significantly increased infant length at birth (10) . Iron was also associated with increased infant length at 3 and 6 mo of age compared with a placebo, although this difference was not statistically significant (10) . In a randomized placebo-controlled trial of iron supplementation in pregnant women in Cleveland, OH, birth length was slightly higher in the Fe-supplemented group, although this result was not statistically significant (58) . However, in a meta-analysis, irononly interventions (n = 27) had no effect on linear growth, whereas multiple micronutrients (n = 20) significantly improved linear growth (59) . A recent randomized trial in Burkina Faso noted a significant cumulative effect of both multiple micronutrients and iron folate on fetal growth (60) . This result was consistent with the growing appreciation of the impact of in utero iron status on developmental programming (61) (62) (63) .
In the current study, we examined breast-milk iron, zinc, and copper concentrations and their associations with infant iron absorption and status prospectively. Iron and copper concentrations at 5M and changes in iron concentrations between 2M and 5M were associated with significantly increased iron absorption at 5M. Breast-milk iron, zinc, and copper molar concentrations were similar to a previous study in Lima, Peru, in breastfeeding mothers at delivery to 6 mo postpartum (64) . Breast-milk iron, zinc, and copper concentrations declined between 2M and 5M (P , 0.001).
To date, there has been a limited assessment of iron absorption in exclusively breastfed, young infants. Few studies have assessed the impact of fetal iron exposure on early infant iron homeostasis (65) , particularly in ID populations. Our analysis was distinct from previous studies because of the young age of infants studied, assessment of both maternal and infant iron status, longitudinal paired iron-absorption measures, selection of infants on the basis of gestational iron exposure, and role of breast-milk micronutrient ratios in iron absorption. To our knowledge, this was the first such longitudinal iron absorption study of 2-5-mo-old infants.
One limitation of this analysis was the lack of data on maternal iron status during pregnancy, delivery practices (eg, cord clamping), and neonatal iron status at birth. These factors would have provided additional information on determinants of early iron homeostasis. Similarly, maternal supplemental iron intake was based on self-report. Because this study was not a randomized trial of iron supplementation, the study design did not rule out the possible influence of other potential confounders, which may have explained the observed associations between iron intake and infant growth. Additional biomarkers, such as hepcidin, or additional measures of inflammation (eg, alpha-1-acid glycoprotein) would have strengthened this analysis.
In conclusion, fetal iron exposure did not significantly affect iron status or absorption in young, exclusively breastfed infants at 2-5 mo of age. However, fetal iron exposure across gestation was associated with significantly improved infant growth, which was a finding that warrants additional investigation. Full-term, exclusively breastfed infants from this community may not be endowed with sufficient body iron to meet the iron requirements needed for the first 6 mo of life. Young infants are able to upregulate iron absorption when iron stores are depleted, as early as 2-5 mo of age, but this may not be adequate to meet iron demands. Thus, young exclusively breastfed infants may be vulnerable to ID and IDA and represent an important risk group. Additional attention needs to be focused on optimizing the iron endowment at birth and characterizing sources of variability in iron absorption and determinants of ID across early infancy. Screening and targeted preventive interventions are needed for ID and anemia in young infants, particularly in settings with high ID burden.
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